Guidelines

Biocodex gets FDA nod for Diacomit
Biocodex has received the FDA nod for Diacomit (stiripentol) for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older taking clobazam.
FDA takes steps to advance guidelines for prescribing opioids
FDA has awarded a contract to the National Academies of Sciences, Engineering, and Medicine (NASEM) to help advance the development of evidence-based guidelines for appropriate opioid analgesic prescribing.

CVS Health: Real-time benefits program reduces drug costs

CVS Health's real-time benefits program saves PBM members between $120-$130 per prescription fill.
Lupin gets tentative FDA green light for generic Natazia tablets

Lupin gets a tentative nod from the FDA for a generic version of Bayer's Natazia tablets, for pregnancy prevention.
FDA acts to mitigate EpiPen shortages

In an effort to end recent shortages of EpiPen auto-injector, the FDA is extending the expiration date of specific lots of products marketed by Mylan.
Generics makers look to keep offerings competitive, affordable

One of the greatest challenges the generics industry has been facing is a product supply shortage that has been caused by a number of generics companies exiting the industry.
Lupin receives FDA nod for two generics

Lupin received the Food and Drug Administration’s approval to launch generic PreCision Locoid lotion and Temovate cream.
Nicholas Hall event highlights a healthy category

Ed Rowland takes a look at the annual Nicholas Hall/Everything Health North American OTC Conference, which once again brought the OTC industry together to discuss industry challenges and opportunities.
Amneal inks licensing deal for levothyroxine

Amneal will market Jerome Steven' generic levothyroxine sodium tablets for hypothyroidism and pituitary TSH suppression.
FDA OKs third Lenvima indication

Eisai and Merck's third approved indication for Lenvima is for the first-line treatment of patients with unresectable hepatocellular carcinoma.

Biocodex gets FDA nod for Diacomit

FDA takes steps to advance guidelines for prescribing opioids

CVS Health: Real-time benefits program reduces drug costs

Lupin gets tentative FDA green light for generic Natazia tablets

FDA acts to mitigate EpiPen shortages

Generics makers look to keep offerings competitive, affordable

Lupin receives FDA nod for two generics

Nicholas Hall event highlights a healthy category

Amneal inks licensing deal for levothyroxine

FDA OKs third Lenvima indication